BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10729775)

  • 1. Molecular breeding of allergy vaccines and antiallergic cytokines.
    Punnonen J
    Int Arch Allergy Immunol; 2000 Mar; 121(3):173-82. PubMed ID: 10729775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of novel vaccines using DNA shuffling and screening strategies.
    Locher CP; Soong NW; Whalen RG; Punnonen J
    Curr Opin Mol Ther; 2004 Feb; 6(1):34-9. PubMed ID: 15011779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of engineered allergen-specific immunotherapy vaccines.
    Focke-Tejkl M; Valenta R
    Curr Opin Allergy Clin Immunol; 2012 Oct; 12(5):555-63. PubMed ID: 22885888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines for allergy treatment.
    Weiss R; Scheiblhofer S; Thalhamer J
    Methods Mol Med; 2006; 127():253-67. PubMed ID: 16988459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental forms of allergen immunotherapy with modified allergens and adjuvants.
    Mohapatra SS; San-Juan-Vergara H; Wopfner N; Ferreira F
    Clin Allergy Immunol; 2008; 21():393-413. PubMed ID: 18828519
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic engineering of allergens: future therapeutic products.
    Ferreira F; Wallner M; Breiteneder H; Hartl A; Thalhamer J; Ebner C
    Int Arch Allergy Immunol; 2002 Jul; 128(3):171-8. PubMed ID: 12119498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA shuffling and vaccines.
    Whalen RG; Kaiwar R; Soong NW; Punnonen J
    Curr Opin Mol Ther; 2001 Feb; 3(1):31-6. PubMed ID: 11249729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of specific immune responses by chemical and structural modifications of allergens.
    Akdis CA; Blaser K
    Int Arch Allergy Immunol; 2000 Apr; 121(4):261-9. PubMed ID: 10828716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA shuffling and screening strategies for improving vaccine efficacy.
    Locher CP; Paidhungat M; Whalen RG; Punnonen J
    DNA Cell Biol; 2005 Apr; 24(4):256-63. PubMed ID: 15812242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allergen-specific immunotherapy: towards combination vaccines for allergic and infectious diseases.
    Edlmayr J; Niespodziana K; Focke-Tejkl M; Linhart B; Valenta R
    Curr Top Microbiol Immunol; 2011; 352():121-40. PubMed ID: 21626347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA vaccines for the prevention and treatment of allergy.
    Chua KY; Kuo IC; Huang CH
    Curr Opin Allergy Clin Immunol; 2009 Feb; 9(1):50-4. PubMed ID: 19532092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming antigenic diversity and improving vaccines using DNA shuffling and screening technologies.
    Locher CP; Heinrichs V; Apt D; Whalen RG
    Expert Opin Biol Ther; 2004 Apr; 4(4):589-97. PubMed ID: 15102607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Future advances of immunotherapy.
    Nelson HS
    Allergy Asthma Proc; 2001; 22(4):203-7. PubMed ID: 11552669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reducing allergenicity by altering allergen fold: a mosaic protein of Phl p 1 for allergy vaccination.
    Ball T; Linhart B; Sonneck K; Blatt K; Herrmann H; Valent P; Stoecklinger A; Lupinek C; Thalhamer J; Fedorov AA; Almo SC; Valenta R
    Allergy; 2009 Apr; 64(4):569-80. PubMed ID: 19243361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering, characterization and in vitro efficacy of the major peanut allergens for use in immunotherapy.
    Bannon GA; Cockrell G; Connaughton C; West CM; Helm R; Stanley JS; King N; Rabjohn P; Sampson HA; Burks AW
    Int Arch Allergy Immunol; 2001; 124(1-3):70-2. PubMed ID: 11306930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy.
    Kussebi F; Karamloo F; Rhyner C; Schmid-Grendelmeier P; Salagianni M; Mannhart C; Akdis M; Soldatova L; Markovic-Housley Z; Von Beust BR; Kündig T; Kemeny DM; Blaser K; Crameri R; Akdis CA
    J Allergy Clin Immunol; 2005 Feb; 115(2):323-9. PubMed ID: 15696088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal, liposome-adjuvanted cockroach allergy vaccines made of refined major allergen and whole-body extract of Periplaneta americana.
    Meechan P; Tungtrongchitr A; Chaisri U; Maklon K; Indrawattana N; Chaicumpa W; Sookrung N
    Int Arch Allergy Immunol; 2013; 161(4):351-62. PubMed ID: 23689057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
    Crameri R
    Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving DNA vaccines targeting viral infection.
    Sin JI; Weiner DB
    Intervirology; 2000; 43(4-6):233-46. PubMed ID: 11251379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination.
    Draghi M; Jarman ER; Grifantini R; Galli-Stampino L; Lamb JR; Valiante NM; Grandi G
    Eur J Immunol; 2002 Dec; 32(12):3720-8. PubMed ID: 12516566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.